Please login or register first to view this content.
Gastrohepatic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Proton Pump Inhibitor Use Linked to Increased Diabetes Risk
Clinical Program for Investigational GERD Drug Discontinued
Prevalence of Adverse Pregnancy Outcomes Assessed With Biologics for IBD
Coffee, Tea, Soda Tied to Higher Risk for Gastroesophageal Reflux
FDA Rejects Terlipressin NDA for Hepatorenal Syndrome Type 1
Dupilumab Gets Breakthrough Therapy Status for Eosinophilic Esophagitis
FDA Fast Tracks SSAO Inhibitor for Nonalcoholic Steatohepatitis
XaraColl Implant Approved for Postop Pain Following Hernia Repair
Postop Nausea, Vomiting Therapy Barhemsys Launched
Antibiotic Exposure Linked to Risk for Inflammatory Bowel Disease
Akynzeo Injection, a New Liquid Formulation, Now Available
Results Mixed for Etrolizumab in Ulcerative Colitis
Reduced CDI Recurrence Observed With Investigational Microbiome Therapy
Ortikos Now Available for Mild to Moderate Crohn Disease
Zenocutuzumab Gets Orphan Drug Designation for Pancreatic Cancer
Clinical Hold Lifted on Seladelpar for Chronic Liver Diseases
Efficacy of Cannabinoids in Treating IBD Examined
GI Bleeding Rates With P2Y12 Platelet Inhibitors Compared